When women ask "am I in perimenopause," medicine actually has a formalized answer. The most widely used research framework is known as STRAW+10 (Stages of Reproductive Aging Workshop + 10), established by leading endocrine, gynecological, and epidemiological societies.

Yet millions of women find standard menopause tracking apps deeply frustrating. The reason is structural: STRAW+10 was defined primarily by menstrual cycle regularity and bleeding intervals. If you have had a hysterectomy, had your ovaries removed, use a hormonal IUD, or have had endometrial ablation, traditional period trackers simply break.

Understanding how clinical reproductive aging actually works, and how dual-track staging fills the gap for non-bleeding transitions, helps transform confusing physiological shifts into clear, objective data.

The clinical framework: Stages of Reproductive Aging (STRAW+10)

The STRAW+10 framework divides adult female reproductive aging into three broad phases (Reproductive, Menopausal Transition, and Postmenopause), spanning seven distinct clinical stages.

Stage -2: early perimenopause (early transition)

The hallmark of Stage -2 is cycle variability. Clinically, this is defined as a persistent difference of 7 or more days in the length of consecutive menstrual cycles. For example, if your typical cycle was 28 days and you begin seeing cycles of 21 days or 35 days, you have crossed the clinical threshold for early transition.

Hormonally, follicle-stimulating hormone (FSH) begins to fluctuate unpredictably rather than rising in a smooth curve. Vasomotor symptoms like occasional hot flashes may start to emerge, particularly in the late luteal phase or during menses.

Stage -1: late perimenopause (late transition)

The late transition is marked by pronounced endocrine volatility and extended intervals of amenorrhea. Clinically, Stage -1 begins with an episode of amenorrhea lasting 60 days or longer.

During this stage, cycles become markedly anovulatory. Estrogen levels swing dramatically between profound nadirs and temporary hyper-estrogenic spikes. Vasomotor symptoms (night sweats, daytime hot flashes) typically peak in frequency and intensity during Stage -1, and sleep fragmentation becomes significantly more pronounced.

Stage +1: postmenopause

Postmenopause is reached after 12 consecutive months of amenorrhea without another biological or physiological cause. The final menstrual period (FMP) represents the boundary line, Stage 0. Stage +1 comprises the first several years following the FMP, during which hormonal stabilization gradually occurs.

The non-bleeding track: surgical, IUD, and induced transitions

Traditional medical staging assumes every woman bleeds regularly until perimenopause. In real clinical practice, tens of millions of women do not.

When bleeding is absent or suppressed, medical providers evaluate alternative neuro-endocrine and physiological markers:

Surgical Menopause (Bilateral Oophorectomy): When both ovaries are surgically removed, the transition is immediate rather than gradual. There is no multi-year Stage -2 or Stage -1; the body transitions abruptly into postmenopause. Symptoms like night sweats and autonomic sleep disruption often emerge acutely within days.
Hysterectomy with Ovarian Conservation: Uterine removal stops bleeding entirely, yet functioning ovaries remain in place. These women still experience biological perimenopause, but cannot track cycle variance. Staging relies on tracking vasomotor onset, sleep architecture changes, and age-adjusted timelines.
Hormonal IUDs (Mirena/Kyleena) & Endometrial Ablation: These therapies thin the endometrial lining to eliminate or minimize bleeding, masking the 7-day or 60-day bleeding thresholds. Transition assessment requires decoupling from period tracking and focusing on systemic symptoms and autonomic nervous system markers.

This is why Liora's free stage assessment on this website uses two tracks: people who still bleed answer STRAW+10-informed cycle questions, while people who do not bleed follow a separate surgical and symptom-timing path. In the app, you choose your stage yourself, including surgical, induced or not sure yet.

The role of biometric telemetry: sleep and HRV

Subjective symptom perception can be unreliable during periods of high stress. This is where passive wearable data from Apple Health bridges the gap.

During perimenopause, nighttime vasomotor events narrow the brain's thermoneutral zone, triggering micro-awakenings that disrupt deep slow-wave sleep and REM cycles. At the same time, autonomic nervous system stress manifests as acute dips in resting Heart Rate Variability (HRV) and elevations in resting heart rate.

In Liora, available Apple Health readings appear beside your own check-ins, with their source. Field Notes describe associations between them, with dates and limits, never causes.

Bringing objective staging to your doctor

Most OB-GYN and primary care visits last between 12 and 15 minutes. When asked "how have your symptoms been," summarizing months of fluctuating hot flashes, mood shifts, and insomnia from memory is challenging.

Arriving at your appointment with your stage in your own words and a one-page brief built around your question, with the records you chose, can change the consultation. Rather than starting from scratch, you and your doctor can immediately discuss evidence-based management options tailored to your exact transition stage.

This article provides educational analysis of published clinical frameworks. It is not medical advice, diagnosis, or treatment, and Liora is not a medical device. Always consult a qualified physician or healthcare provider regarding medical symptoms or staging questions.

The stages of perimenopause: how STRAW+10 and non-bleeding tracks work